作为医院病原体的物种：流行病学和耐药特征
spp. as nosocomial pathogens: Epidemiology and resistance features.
作者信息
Almasaudi Saad B
机构信息
Biology Department, Faculty of Science, King Abdulaziz University (KAU), P.O. Box 80203, Jeddah 21589, Saudi Arabia.
出版信息
Saudi J Biol Sci. 2018 Mar;25(3):586-596. doi: 10.1016/j.sjbs.2016.02.009. Epub 2016 Feb 11.
Abstract
The genus is a major cause of nosocomial infections; it is increasingly being associated with various epidemics and has become a widespread concern in a variety of hospitals worldwide. Multi-antibiotic resistant , is now recognized to be of great clinical significance. Numerous reports relay to the spread of . in the hospital settings which leads to enhanced nosocomial outbreaks associated with high death rates. However, many other spp. also can cause nosocomial infections. This review focused on the role of spp. as nosocomial pathogens in addition to their persistence, antimicrobial resistance patterns and epidemiology.
摘要
该属是医院感染的主要原因；它越来越多地与各种疫情相关联，并已成为全球各类医院广泛关注的问题。多重耐药的[具体菌名未给出]现已被认为具有重大临床意义。许多报告都提到了[具体菌名未给出]在医院环境中的传播，这导致与高死亡率相关的医院感染暴发增加。然而，许多其他[具体菌名未给出]种也可引起医院感染。本综述重点关注了[具体菌名未给出]种作为医院病原体的作用，以及它们的持续性、抗菌耐药模式和流行病学。
相似文献
1
spp. as nosocomial pathogens: Epidemiology and resistance features.
Saudi J Biol Sci. 2018 Mar;25(3):586-596. doi: 10.1016/j.sjbs.2016.02.009. Epub 2016 Feb 11.
2
A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids.
Indian J Med Res. 2008 Aug;128(2):178-87.
3
[Epidemiology and clinical features of Acinetobacter baumannii infections in humans].
Berl Munch Tierarztl Wochenschr. 2014 Nov-Dec;127(11-12):447-57.
4
Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.
PLoS One. 2021 Nov 15;16(11):e0257272. doi: 10.1371/journal.pone.0257272. eCollection 2021.
5
spp. Infections in Malaysia: A Review of Antimicrobial Resistance Trends, Mechanisms and Epidemiology.
Front Microbiol. 2017 Dec 12;8:2479. doi: 10.3389/fmicb.2017.02479. eCollection 2017.
6
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Microb Pathog. 2019 Mar;128:75-81. doi: 10.1016/j.micpath.2018.12.023. Epub 2018 Dec 15.
7
Nosocomial Acinetobacter pneumonia.
Respirology. 2007 Nov;12(6):787-91. doi: 10.1111/j.1440-1843.2007.01147.x.
8
Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens.
Yonsei Med J. 2011 Nov;52(6):879-91. doi: 10.3349/ymj.2011.52.6.879.
9
Association between antimicrobial resistance among Enterobacteriaceae and burden of environmental bacteria in hospital acquired infections: analysis of clinical studies and national reports.
Heliyon. 2019 Jul 22;5(7):e02054. doi: 10.1016/j.heliyon.2019.e02054. eCollection 2019 Jul.
10
Blue light irradiation triggers the antimicrobial potential of ZnO nanoparticles on drug-resistant Acinetobacter baumannii.
J Photochem Photobiol B. 2018 Mar;180:235-242. doi: 10.1016/j.jphotobiol.2018.02.003. Epub 2018 Feb 6.
引用本文的文献
1
Contamination of hospital surfaces by third-generation cephalosporin-resistant gram-negative bacteria in district hospitals in Mwanza, Tanzania: Urgent need for enhanced infection prevention and control.
Infect Prev Pract. 2025 Jul 5;7(3):100475. doi: 10.1016/j.infpip.2025.100475. eCollection 2025 Sep.
2
Microbial prevalence and understanding of their antimicrobial susceptibility in urinary tract of patients attending at shar teaching hospital (2018-2022).
BMC Res Notes. 2025 Jul 28;18(1):329. doi: 10.1186/s13104-025-07361-6.
3
Distribution of and and the pathogens they are carrying: A systematic review.
Parasite Epidemiol Control. 2025 Jun 4;30:e00437. doi: 10.1016/j.parepi.2025.e00437. eCollection 2025 Aug.
4
Clinical and Epidemiological Aspects on Healthcare-Associated Infections with spp. in a Neurosurgery Hospital in North-East Romania.
Medicina (Kaunas). 2025 May 27;61(6):990. doi: 10.3390/medicina61060990.
5
Molecular Epidemiology and MLST-Based Typing of Pandrug-Resistant Clinical Isolates in Iraq: A Cross-Sectional Study.
Iran J Pathol. 2025 Spring;20(2):173-180. doi: 10.30699/ijp.2025.2052426.3412. Epub 2025 Mar 10.
6
Prevalence and antimicrobial resistance of in the livestock industry in South Korea under a One Health perspective.
One Health. 2025 May 11;20:101071. doi: 10.1016/j.onehlt.2025.101071. eCollection 2025 Jun.
7
The intricacies of : a multifaceted comprehensive review of a multidrug-resistant pathogen and its clinical significance and implications.
Front Microbiol. 2025 May 12;16:1565965. doi: 10.3389/fmicb.2025.1565965. eCollection 2025.
8
Prevalence and Antibiogram Pattern of from 2013 to 2023 in a Tertiary Care Hospital in the Western Region of Saudi Arabia.
Antibiotics (Basel). 2025 Mar 7;14(3):274. doi: 10.3390/antibiotics14030274.
9
The Evolving Landscape of Infective Endocarditis: Difficult-to-Treat Resistance Bacteria and Novel Diagnostics at the Foreground.
J Clin Med. 2025 Mar 19;14(6):2087. doi: 10.3390/jcm14062087.
10
Inhibitory Effect of Antimicrobial Peptides Bac7(17), PAsmr5-17 and PAβN on Bacterial Growth and Biofilm Formation of Multidrug-Resistant .
Microorganisms. 2025 Mar 11;13(3):639. doi: 10.3390/microorganisms13030639.
本文引用的文献
1
Acinetobacter infections and outcomes at an academic medical center: a disease of long-term care.
Open Forum Infect Dis. 2015 Mar 12;2(1):ofv023. doi: 10.1093/ofid/ofv023. eCollection 2015 Jan.
2
Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates of Acinetobacter baumannii in China.
J Chemother. 2016 Oct;28(5):443-5. doi: 10.1179/1973947815Y.0000000017. Epub 2016 Jul 22.
3
Prevalence of eight resistance-nodulation-division efflux pump genes in epidemiologically characterized Acinetobacter baumannii of worldwide origin.
J Med Microbiol. 2015 Jun;64(6):630-635. doi: 10.1099/jmm.0.000069. Epub 2015 Apr 14.
4
Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia.
Expert Rev Anti Infect Ther. 2015 Jun;13(6):769-77. doi: 10.1586/14787210.2015.1032254. Epub 2015 Apr 12.
5
Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.
Int J Antimicrob Agents. 2015 Jun;45(6):568-85. doi: 10.1016/j.ijantimicag.2015.03.001. Epub 2015 Mar 24.
6
Growth phase-specific evolutionary benefits of natural transformation in Acinetobacter baylyi.
ISME J. 2015 Oct;9(10):2221-31. doi: 10.1038/ismej.2015.35. Epub 2015 Apr 7.
7
Resources for Genetic and Genomic Analysis of Emerging Pathogen Acinetobacter baumannii.
J Bacteriol. 2015 Jun 15;197(12):2027-35. doi: 10.1128/JB.00131-15. Epub 2015 Apr 6.
8
Tetracyclines for multidrug-resistant Acinetobacter baumannii infections.
Int J Antimicrob Agents. 2015 May;45(5):455-60. doi: 10.1016/j.ijantimicag.2014.12.031. Epub 2015 Feb 16.
9
Burden of bacterial meningitis: a retrospective review on laboratory parameters and factors associated with death in meningitis, kelantan malaysia.
Nagoya J Med Sci. 2015 Feb;77(1-2):59-68.
10
Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients.
Int J Antimicrob Agents. 2015 Jun;45(6):670-1. doi: 10.1016/j.ijantimicag.2015.02.005. Epub 2015 Feb 26.
Zotero 插件